Table 2.
Baseline characteristics in patients with or without treadmill exercise testing
| TET (N = 26) | No TET (N = 14) | P value | |
|---|---|---|---|
| Age (years) | 52.8 ± 12.4 | 57.5 ± 9.4 | 0.233 |
| Weight (Kg) | 76.3 ± 19.4 | 72.0 ± 13.0 | 0.471 |
| Male, N (%) | 20 (76.9) | 10 (71.4) | 0.702 |
| LVEF (%) | 43.9 ± 5.7 | 45.8 ± 5.9 | 0.346 |
| NYHA class | 2.1 ± 0.5 | 2.3 ± 0.7 | 0.318 |
| LVESD (mm) | 47.5 ± 6.5 | 42.8 ± 8.5 | 0.062 |
| LVEDD (mm) | 60.5 ± 6.8 | 57.2 ± 8.8 | 0.208 |
| 6MHW (m) | 451.4 ± 61.8 | 344.1 ± 83.9 | <0.001 |
| BNP (pg/mL) | 119.4 ± 123.8 | 119.8 ± 336.1 | 0.294 |
| CAD, N (%) | 9 (34.6) | 5 (35.7) | 0.945 |
| Cardiomyopathy, N (%) | 23 (88.5) | 12 (85.7) | 0.802 |
| Β-blocker, N (%) | 25 (96.2%) | 13 (92.9) | 0.648 |
TET treadmill exercise testing